The Journey to Diagnosis in AS/axial SpA: the Impact of Delay
Overview
Authors
Affiliations
Objectives: The aim of the present study was to conduct an in-depth exploration of the 'journey' to diagnosis of people with ankylosing spondylitis (AS)/axial spondyloarthritis (Axial SpA) to gain insights into the experience, potential barriers and facilitators in this process.
Methods: The present qualitative study, embedded within a prospective longitudinal cohort study, was located within an interpretive phenomenological paradigm. Ten people newly diagnosed with AS/axial SpA, reporting an average of 10.1 [standard deviation (SD) 7.3] years between experiencing symptoms and diagnosis, participated in semi-structured interviews. The interviews were recorded, transcribed and analysed thematically. Ethical approval and informed consent were obtained.
Results: Analysis identified four key themes: 'What's going on?' described the process associated with trying to understanding a changing body experience complicated by variability and the severity of back pain experienced. 'Fighting for a diagnosis' provided insights into the process of having to 'fight' to be believed and feeling dismissed by healthcare professionals. 'Being adrift' explored the negative psychological consequences associated with a search for a diagnosis. 'The start of a journey' described the relief associated with receiving a diagnosis, juxtaposed against emotions associated with the diagnosis of a long-term degenerative condition.
Conclusions: The delay in diagnosis experienced may be associated with lack of familiarity and knowledge of AS/axial SpA in the population and in healthcare professionals, and creates a multiplicity of problems, including psychological distress. Clinicians therefore need to consider the potential impact of a person's 'journey to diagnosis' on clinical management once a diagnosis has been made.
Ingram T, Eddison J, Gaffney K, Sengupta R, Murphy D, Wallace T Br J Gen Pract. 2025; 75(752):136-139.
PMID: 40016110 PMC: 11892762. DOI: 10.3399/bjgp25X740997.
May S, Nordmann G, Gabb F, Boy K, Wagner M, Ohm N BMC Rheumatol. 2025; 9(1):14.
PMID: 39934914 PMC: 11818133. DOI: 10.1186/s41927-025-00465-3.
Berr K, Ziehfreund S, Welcker M, Biedermann T, Zink A Sci Rep. 2024; 14(1):19977.
PMID: 39198468 PMC: 11358462. DOI: 10.1038/s41598-024-70420-8.
Barriers and facilitators in diagnosing axial spondyloarthritis: a qualitative study.
Hay C, Packham J, Prior J, Mallen C, Ryan S Rheumatol Int. 2024; 44(5):863-884.
PMID: 38472441 PMC: 10980652. DOI: 10.1007/s00296-024-05554-z.
Luchetti Gentiloni M, Paci V, Cimaroli I, Agostinelli A, Giannoni M, Campanati A Rheumatology (Oxford). 2023; 63(8):2152-2161.
PMID: 37878802 PMC: 11292137. DOI: 10.1093/rheumatology/kead566.